P294 12 Pill: white, round, 8mm
The pill with imprint P294 12 (White, Round, 8mm) has been identified as Hydromorphone Hydrochloride Extended-Release 12 mg and is used for Chronic Pain, Pain, Anesthetic Adjunct, and Cough. It belongs to the drug class Opioids (narcotic analgesics) and is classified as CSA Schedule 2 (High potential for abuse).
Images for P294 12
Hydromorphone Hydrochloride Extended-Release
- Imprint
- P294 12
- Strength
- 12 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Paddock Laboratories, LLC
- National Drug Code (NDC)
- 00574-0294
- Inactive Ingredients
-
microcrystalline cellulose,
lactose monohydrate,
silicon dioxide,
magnesium stearate,
ethylcellulose (100 mPa.s),
povidone k30,
triethyl citrate,
ammonio methacrylate copolymer type A,
magnesium silicate,
hypromellose 2910 (3 mPa.s),
hypromellose 2910 (6 mPa.s),
polyethylene glycol 400,
titanium dioxide,
FD&C Blue No. 1,
propylene glycol,
polysorbate 80
Note: Inactive ingredients may vary.
See also:
More about hydromorphone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (450)
- Drug images
- Latest FDA alerts (12)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
- Hydromorphone drug information
- Hydromorphone injection
- Hydromorphone rectal
- Hydromorphone Extended-Release Tablets
- Hydromorphone Liquid
Other brands
Dilaudid, Exalgo, Dilaudid-HP, Palladone
Professional resources
- Hydromorphone Hydrochloride monograph
- Hydromorphone (FDA)
- Hydromorphone Extended Release (FDA)
- Hydromorphone Injection (FDA)
- Hydromorphone Oral Solution (FDA)
Other brands
Dilaudid, Exalgo, Dilaudid-HP, Palladone
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.